Quantum Leap Healthcare Collaborative
The I-SPY Trials
For Patients
ABOUT
I-SPY 2 Trial
Resources
Funding & Support
Agents & Results
I-SPY Agents
Manuscripts
Meeting Abstracts
Collaborate
Proposal Submissions
Partner With Us
News
Latest News
Feature Articles
I-SPY in the News
Media Center
People
Leadership
Clinical Sites
Contact Us
FOR PATIENTS
News
I-SPY in the News
Widely hailed as the future of phase II drug development, the adaptive I-SPY2 platform trial has set a new benchmark for efficiency, through innovation in trial design and clinical operations.
Close
Close
Close
I-SPY Email List Sign-up
First Name:
Last Name:
Email Address:
Breast cancer patient/family/friend
Research/Medical Professional
Just Interested
Thank you, your subscription is activated.
If you change your mind, you can
unsubscribe
at any time.
Oops! Something went wrong while submitting the form.
Highlights
I-SPY updates breast cancer subtypes with response-predictive biomarkers generated across 10 therapies
Cancer Cell
June 14, 2022
Esserman brings urgency for ‘learning healthcare’ to learn faster, better
BioCentury
June 6, 2022
Natera to Present Data from the BEATRICE and I-SPY2 Trials in Early-Stage TNBC and HR+/HER2- Breast Cancer at the 2022 AACR Annual Meeting
Natera, Inc.
April 11, 2022
Recent Coverage
June 14, 2022
-
Cancer Cell
I-SPY updates breast cancer subtypes with response-predictive biomarkers generated across 10 therapies
June 6, 2022
-
BioCentury
Esserman brings urgency for ‘learning healthcare’ to learn faster, better
April 11, 2022
-
Natera, Inc.
Natera to Present Data from the BEATRICE and I-SPY2 Trials in Early-Stage TNBC and HR+/HER2- Breast Cancer at the 2022 AACR Annual Meeting
October 1, 2020
-
Dr. Laura Esserman among recipients of 2020 Brinker Awards for Scientific Distinction
December 31, 2018
-
Healio
Genomic tests predict response to therapy in breast cancer subtypes
November 28, 2018
-
ASCO Post
Genomic Testing in Breast Cancer May Enhance Personalized Treatment: Update of I-SPY 2
November 20, 2018
-
BioPharmDrive
FDA's Woodcock: 'The clinical trial system is broken'
September 12, 2018
-
CBS NY
Health Watch: Testing Breast Cancer Drugs To Avoid Surgery
May 29, 2018
-
Agendia
MammaPrint and BluePrint's use in Personalizing Neoadjuvant Treatment Approaches for Early-Stage Breast Cancer Patients
April 9, 2018
-
OncLive
Immunotherapy for Triple-Negative Breast Cancer
February 21, 2018
-
U Chicago ForeFront
Clinical trial, team approach help breast cancer patient survive and thrive
January 26, 2018
-
MedCity News
UCSF-led clinical trial model may present a better way to test new breast cancer drugs
Next
Don't miss a thing! Get I-SPY results, news and event information delivered right to your inbox.
Sign Up
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.